Navigation Links
Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
Date:11/5/2007

X-208 on serum ApoA-I levels, HDL subspecies distribution and the functional improvements of serum to promote cellular cholesterol efflux from vulnerable plaque cells. The mere fact that the data is based on African Green monkeys in a context of dose-response makes it predictive for similar treatment effects in humans.

About Cardiovascular Disease (CVD)

CVD can be generally defined as any abnormal condition characterized by dysfunction of the heart and blood vessels. CVD includes atherosclerosis (especially coronary heart disease which can lead to heart attacks), cerebrovascular disease (stroke), and hypertension (high blood pressure). The underlying cause of most CVD is a gradual clogging of the arteries (atherosclerosis) that supply blood to the heart, brain and other vital organs.

The American Heart Association estimates that almost 80 million American Adults have one or more types of cardiovascular disease. CVD remains the number one killer of developed nations. Nearly 2400 Americans die each day from cardiovascular disease - that is 1 person will die every 36 seconds.

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer's and other vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a program that aims to address burgeoning grievous diseases, such as cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit http://www.resverlogix.com.

This news release may contain certain forward-looking
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. Viragen International to Reverse Split Its Common Stock
3. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
4. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
5. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
6. Bioscrypts V-Station MIFARE Placed on Transportation Security Administrations Qualified Products List
7. Mechanism for the in-vivo transport of siRNA
8. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
9. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
10. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , LIBREVILLE, Gabon, December 2 /...ty in Africa: Everyone,s Problem and Heritage" ,...Biodiversity, 2-3 June 2010 the,Gabonese Republic ...le,(Gabon) on the issue of safeguarding biological...ded by government and state leaders, ministers,sc...
(Date:12/2/2009)... , , RESTON, Va., Dec. 2 /PRNewswi...d Dairy" or the "Company") (OTC Bulletin Board: EM...and children,s formula, milk powder and,soybean pr...will be featured,in the Spring issue of US Food &a...eadership of over 250,000 executives in the food a...
(Date:12/2/2009)... , , HOBOKEN, N.J., Dec. 2 /PRNewswire/ ...40 percent to 45 percent of Americans diagnosed wi...tinopathy. Diabetic retinopathy, damage to the re...se of blindness in people with diabetes and is one...ct, up to 80 percent of all patients who,ve had di...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,...pe: Market dynamics and the changing healthcare an...linker.com/p0165658/Emerging-Clinical-Trial-Locati...ing-healthcare-and-regulatory-environment.html ,...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...Dynamic Alert,Limited (OTC Bulletin Board: DYMC) i...ts target markets for its pharmaceutical product l... some capacity for enhancing rapid onset,through o...s lotions and,salves, and various products for int...while others may treat a range of problems. In kee...
...l experience with the FDA,cleared Visica 2(TM) Tre...fectiveness of ultrasound guided cryoablation to c...l Breast Cancer (IDC). Initial data from this,mul...ic Assembly and Annual,Meeting of the Radiological...cember 5, 2008. , The study, "New Findings o...
...enesco Technologies, Inc. ("Senesco" or the "Compa... its Development and License Agreement with the h...erminated by mutual agreement because of Harris Mo... , , Harris Moran has reported that its paren...eed operations and that Harris Moran will now be p...
Other Biology Technology:Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products 2Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products 3Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA 2Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA 3Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring 2Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring 3
(Date:12/2/2009)... New York, NY, December 2, 2009 Commonly prescrib...nt of asthma in pregnant women as well as pre-term...um disorders, psychiatric pathology, cognitive pro...n, according to a new study published in the Decem...ics & Gynecology . , Beta 2 adrenergic agonist d...
(Date:12/1/2009)... Broadly speaking, ants have two different feeding...e "carnivorous," meaning that they are generalist ...ging on their remains. Some, however, are "herbiv...nts; rather, the bulk of their diets consist of pl...icky fluids produced by plants to attract ants, ca...
(Date:12/1/2009)... Particularly in Alzheimer,s disease, nerve cell d...ew therapeutic options may possibly be derived fro...sm. These findings have been published in the curr...ence . Until only a few years ago, neurogenesis t...ed to be impossible in the adult brain. The textbo...
Breaking Biology News(10 mins):Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New source discovered for the generation of nerve cells in the brain 2Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 1Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 2Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 3Abaxis to Report First Quarter Fiscal 2010 Financial Results Thursday July 30 2009 52506 1Abaxis to Report First Quarter Fiscal 2010 Financial Results Thursday July 30 2009 52506 2Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 1Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 2
... people, but the disease can place a special burde...atients on chemotherapy. A five-year, $10.7 millio...adelphia will support research to determine how ad... be uniquely vulnerable to influenza, and will see... with compromised immune systems may be contagious...
...cently derived human gene trees by Alan R. Templet...ows three distinct major waves of human migration ...lly refutes –strongly ?the ,Out of Africa, replace...of Homo sapiens left Africa 100,000 years ago and ...on has shown that the African populations interbre...
...f Science, their lizard study describes how the "s...al, eye, distinguishes two different colors, blue ...alized nerve cells in that eye, which looks more l... of molecular signals to sense light: those found ...found only in more complex animals like humans. ,...
Other Biology News:How can we protect patients with weakened immune systems from influenza? 2How can we protect patients with weakened immune systems from influenza? 3New analysis shows three human migrations out of Africa 2Lizard 'third eye' sheds light on evolution of color vision 2
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
...pidly and reliably amplify unknown genomic DNA us...hassle-free, ready-to use components, at an extrao...ents are provided in each kit. The Genome Walking ... of genomic DNA, isolating promoter and regulatory...
Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam
Bovine Calf Serum - 500mL from GeneTex
Biology Products: